Lisa Bomgaars

3.9k total citations
57 papers, 2.3k citations indexed

About

Lisa Bomgaars is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Lisa Bomgaars has authored 57 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 17 papers in Cardiology and Cardiovascular Medicine and 11 papers in Molecular Biology. Recurrent topics in Lisa Bomgaars's work include Blood Coagulation and Thrombosis Mechanisms (16 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Cancer therapeutics and mechanisms (9 papers). Lisa Bomgaars is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (16 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Cancer therapeutics and mechanisms (9 papers). Lisa Bomgaars collaborates with scholars based in United States, Canada and Germany. Lisa Bomgaars's co-authors include Susan M. Blaney, Stacey L. Berg, Patrick A. Thompson, M. Patricia Massicotte, Richard Kadota, Luisa M. Rodríguez, Rubina A. Heptulla, Mark Krailo, Peter C. Adamson and Victor S. Blanchette and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Lisa Bomgaars

57 papers receiving 2.3k citations

Peers

Countries citing papers authored by Lisa Bomgaars

Since Specialization

Citations

This map shows the geographic impact of Lisa Bomgaars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Bomgaars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Bomgaars more than expected).

Fields of papers citing papers by Lisa Bomgaars

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Bomgaars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Bomgaars. The network helps show where Lisa Bomgaars may publish in the future.

Co-authorship network of co-authors of Lisa Bomgaars

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Bomgaars. A scholar is included among the top collaborators of Lisa Bomgaars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Bomgaars. Lisa Bomgaars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease 2024 ·Journal of the American Heart Association ·Manuela Albisetti, Igor Tartakovsky, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers, Lesley Mitchell, Matteo Luciani, Ildar Nurmeev, (unknown), (unknown), Martina Brueckmann, Leonardo R. Brandão, (unknown)	4
2	Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia 2022 ·Blood Advances ·Leonardo R. Brandão, Igor Tartakovsky, Manuela Albisetti, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers, Matteo Luciani, Paola Saracco, Judy Felgenhauer, O. Lvova, (unknown), Zhichao Sun, Lesley Mitchell	4
3	Abstract 9192: Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children With Congenital Heart Disease 2021 ·Circulation ·Manuela Albisetti, Igor Tartakovsky, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers, Lesley Mitchell, Matteo Luciani, Ildar Nurmeev, (unknown), Eva Kleine, Martina Brueckmann, Leonardo R. Brandão	1
4	Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group 2021 ·Pediatric Blood & Cancer ·Anderson B. Collier, Mark Krailo, Ha Dang, Steven G. DuBois, Douglas S. Hawkins, Mark L. Bernstein, Lisa Bomgaars, Damon R. Reed, Richard Görlick, Katherine A. Janeway	13
5	Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children 2019 ·Blood ·Leonardo R. Brandão, Manuela Albisetti, (unknown), Lisa Bomgaars, Elizabeth Chalmers, Lesley Mitchell, Ildar Nurmeev, Pavel Svirin, (unknown), Ondřej Zapletal, Igor Tartakovsky, (unknown), Fenglei Huang, Zhichao Sun, Jörg Kreuzer, Savion Gropper, Martina Brueckmann, Matteo Luciani	64
6	The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group 2019 ·Clinical Pharmacokinetics ·(unknown), Patrick A. Thompson, (unknown), (unknown), Lisa Bomgaars, (unknown), ZoAnn E. Dreyer, Daniel González	27
7	Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design 2018 ·Research and Practice in Thrombosis and Haemostasis ·Matteo Luciani, Manuela Albisetti, Branislav Biss, Lisa Bomgaars, Martina Brueckmann, Elizabeth Chalmers, Savion Gropper, (unknown), Ruth Harper, Fenglei Huang, (unknown), Lesley Mitchell, Igor Tartakovsky, Bushi Wang, Leonardo R. Brandão	9
8	Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency 2016 ·Thrombosis and Haemostasis ·Marilyn J. Manco‐Johnson, Lisa Bomgaars, (unknown), Amy D. Shapiro, John D. Geil, Sandor Fritsch, Borislava G. Pavlova, David Gelmont	23
9	Response to Warfarin Therapy in Obese Pediatric Patients Dosed According to Institutional Guidelines 2014 ·Journal of Pediatric Hematology/Oncology ·Brady S. Moffett, Lisa Bomgaars	6
10	Prospective Trial of a Pediatric Ventricular Assist Device 2012 ·New England Journal of Medicine ·Charles D. Fraser, Robert D.B. Jaquiss, David N. Rosenthal, Tilman Humpl, Charles E. Canter, Eugene H. Blackstone, (unknown), Rebecca Ichord, Lisa Bomgaars, James S. Tweddell, M. Patricia Massicotte, Mark W. Turrentine, (unknown), Eric J. Devaney, (unknown), Kathleen E. Carberry, Robert Kroslowitz, Christopher S. Almond	318
11	A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia 2011 ·Blood ·James B. Bussel, George R. Buchanan, Diane J. Nugent, David J. Gnarra, Lisa Bomgaars, Victor S. Blanchette, (unknown), Kun Nie, (unknown)	157
12	Pilot study of the effect of romiplostim on child health‐related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP) 2011 ·Pediatric Blood & Cancer ·Robert J. Klaassen, Susan D. Mathias, George R. Buchanan, James B. Bussel, Robert Deuson, Nancy L. Young, Anderson B. Collier, Lisa Bomgaars, Victor S. Blanchette	39
13	Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients 2011 ·Pediatric Blood & Cancer ·Brady S. Moffett, (unknown), Lisa Bomgaars	16
14	Development of Factor V and Thrombin Inhibitors in Children Following Bovine Thrombin Exposure during Cardiac Surgery: A Report of Three Cases 2010 ·Congenital Heart Disease ·Lisa Bomgaars, Kathleen E. Carberry, Charles D. Fraser, (unknown), Jun Teruya	2
15	Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group 2008 ·Cancer Chemotherapy and Pharmacology ·Patrick A. Thompson, Manish Gupta, Gary L. Rosner, Alexander Yu, Jeffrey S. Barrett, Lisa Bomgaars, Mark L. Bernstein, Susan M. Blaney, John Mondick	21
16	Valacyclovir and acyclovir pharmacokinetics in immunocompromised children 2008 ·Pediatric Blood & Cancer ·Lisa Bomgaars, Patrick Thompson, Stacey L. Berg, (unknown), (unknown), Susan M. Blaney	15
17	Ontogeny of Dextromethorphan O- and N-demethylation in the First Year of Life 2007 ·Clinical Pharmacology & Therapeutics ·Michael Blake, Andrea Gaedigk, Robin E. Pearce, Lisa Bomgaars, Michael L. Christensen, Cindy D. Stowe, Laura P. James, John T. Wilson, Gregory L. Kearns, J. Steven Leeder	128
18	Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia 2006 ·Journal of Clinical Oncology ·Sima Jeha, Paul S. Gaynon, Bassem I. Razzouk, Janet Franklin, Richard Kadota, Violet Shen, Lori Luchtman‐Jones, Michael Rytting, Lisa Bomgaars, Susan R. Rheingold, Kim Ritchey, Edythe A. Albano, R.J. Arceci, Stewart Goldman, Timothy J. Griffin, Arnold J. Altman, Bruce G. Gordon, Laurel J. Steinherz, Steven Weitman, Peter G. Steinherz	215
19	Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia 2006 ·Cancer Chemotherapy and Pharmacology ·Patrick A. Thompson, Daryl J. Murry, Gary L. Rosner, Simón Lunagómez, Susan M. Blaney, Stacey L. Berg, Bruce M. Camitta, ZoAnn E. Dreyer, Lisa Bomgaars	30
20	A phase I study of irinotecan administered on a weekly schedule in pediatric patients 2005 ·Pediatric Blood & Cancer ·Lisa Bomgaars, (unknown), Stacey L. Berg, John F. Kuttesch, (unknown), Susan M. Blaney	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact